HomeCUV • ASX
Follow
Clinuvel Pharmaceuticals Limited
Previous close
$14.18
Day range
$14.03 - $14.60
Year range
$12.96 - $21.53
Market cap
719.83M AUD
Avg Volume
163.36K
P/E ratio
24.65
Dividend yield
0.35%
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 16.40M | 11.70% |
Operating expense | 8.23M | 38.98% |
Net income | 5.47M | -3.97% |
Net profit margin | 33.34 | -14.03% |
Earnings per share | — | — |
EBITDA | 7.24M | -1.10% |
Effective tax rate | 26.14% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 174.45M | 23.98% |
Total assets | 211.68M | 32.06% |
Total liabilities | 33.03M | 56.39% |
Total equity | 178.65M | — |
Shares outstanding | 49.55M | — |
Price to book | 3.93 | — |
Return on assets | 8.21% | — |
Return on capital | 9.67% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 5.47M | -3.97% |
Cash from operations | 13.19M | 25.48% |
Cash from investing | -8.01M | 28.14% |
Cash from financing | -1.32M | -22.76% |
Net change in cash | 3.46M | 356.93% |
Free cash flow | 4.17M | -30.07% |
About
Founded
1987
Website
Employees
16